Mahaney Paige
Insider CIK 2040313 · CCCC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2026-02-14 | 2026-02-18 | 2,446 | $1.89 | $4.6K | 336,910 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2026-02-14 | 2026-02-18 | 7,050 | — | $0 | 339,356 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2026-02-13 | 2026-02-18 | 240,000 | — | $0 | 339,356 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2025-10-28 | 2025-10-30 | 5,644 | $2.58 | $14.6K | 99,356 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2025-10-28 | 2025-10-30 | 19,200 | — | $0 | 105,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-02-14 | 2025-02-18 | 42,400 | — | $0 | 42,400 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-02-14 | 2025-02-18 | 28,200 | — | $0 | 105,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-10-28 | 2024-10-29 | 345,600 | — | $0 | 345,600 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-10-28 | 2024-10-29 | 76,800 | — | $0 | 76,800 | SEC↗ |